Cargando…

Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer

BACKGROUND: microRNAs (miRNAs) and N6‐methyladenosine (m(6)A) play important roles in ovarian cancer (OvCa). However, the mechanisms by which miRNAs regulate m(6)A in OvCa have not been elucidated so far. METHODS: To screen m(6)A‐related miRNAs, Pearson's correlation analysis of miRNAs and m(6)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qiulei, Li, Guoqing, Gong, Lanqing, Cai, Jing, Chen, Le, Xu, Xiaohan, Liu, Xiaoli, Zhao, Jing, Zeng, Ya, Gao, Rui, Yu, Lili, Wang, Zehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972042/
https://www.ncbi.nlm.nih.gov/pubmed/36259156
http://dx.doi.org/10.1002/cam4.5246
_version_ 1784898235940208640
author Wu, Qiulei
Li, Guoqing
Gong, Lanqing
Cai, Jing
Chen, Le
Xu, Xiaohan
Liu, Xiaoli
Zhao, Jing
Zeng, Ya
Gao, Rui
Yu, Lili
Wang, Zehua
author_facet Wu, Qiulei
Li, Guoqing
Gong, Lanqing
Cai, Jing
Chen, Le
Xu, Xiaohan
Liu, Xiaoli
Zhao, Jing
Zeng, Ya
Gao, Rui
Yu, Lili
Wang, Zehua
author_sort Wu, Qiulei
collection PubMed
description BACKGROUND: microRNAs (miRNAs) and N6‐methyladenosine (m(6)A) play important roles in ovarian cancer (OvCa). However, the mechanisms by which miRNAs regulate m(6)A in OvCa have not been elucidated so far. METHODS: To screen m(6)A‐related miRNAs, Pearson's correlation analysis of miRNAs and m(6)A regulators was implemented using The Cancer Genome Atlas database (TCGA). To determine the level of m(6)A, RNA m(6)A quantitative assays were used. Then, colony formation assays, EdU assays, wound healing assays, and Transwell assays were performed. The dual‐luciferase reporter assay was used to confirm the miRNA target genes. Protein–protein interaction (PPI) analysis of the target genes was performed, and hub genes were discovered using the cytoHubba/Cytoscape software. The underlying molecular mechanisms were explored by bioinformatics and RNA stability assays. RESULTS: A total of 126 miRNAs were identified as m(6)A‐related miRNAs by Pearson's correlation analysis. Among them, the high level of miR‐30c‐5p was associated with good prognosis in OvCa patients. In vitro, the miR‐30c‐5p agomir lowered the m(6)A level and inhibited OvCa cell proliferation, migration, and invasion. The hub target genes of miR‐30c‐5p were identified as (i) XPO1, (ii) AGO1, (iii) HNRNPA2B1, of which m(6)A reader HNRNPA2B1 was highly expressed in OvCa tissues and related with poor prognosis. In vitro, knockdown of HNRNPA2B1 significantly reduced m(6)A level and hampered the proliferation and migration of OvCa cells. The inhibition of m(6)A reader HNRNPA2B1 attenuated the suppression of proliferation and migration and the low m(6)A level induced by the miR‐30c‐5p downregulation. Mechanistically, m(6)A reader HNRNPA2B1 might regulate CDK19 mRNA stability to alter m(6)A level. CONCLUSIONS: miR‐30c‐5p inhibits OvCa progression and reduces the m(6)A level by inhibiting m(6)A reader HNRNPA2B1, thus providing new insights into the m(6)A regulatory mechanism in OvCa.
format Online
Article
Text
id pubmed-9972042
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99720422023-03-01 Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer Wu, Qiulei Li, Guoqing Gong, Lanqing Cai, Jing Chen, Le Xu, Xiaohan Liu, Xiaoli Zhao, Jing Zeng, Ya Gao, Rui Yu, Lili Wang, Zehua Cancer Med Research Articles BACKGROUND: microRNAs (miRNAs) and N6‐methyladenosine (m(6)A) play important roles in ovarian cancer (OvCa). However, the mechanisms by which miRNAs regulate m(6)A in OvCa have not been elucidated so far. METHODS: To screen m(6)A‐related miRNAs, Pearson's correlation analysis of miRNAs and m(6)A regulators was implemented using The Cancer Genome Atlas database (TCGA). To determine the level of m(6)A, RNA m(6)A quantitative assays were used. Then, colony formation assays, EdU assays, wound healing assays, and Transwell assays were performed. The dual‐luciferase reporter assay was used to confirm the miRNA target genes. Protein–protein interaction (PPI) analysis of the target genes was performed, and hub genes were discovered using the cytoHubba/Cytoscape software. The underlying molecular mechanisms were explored by bioinformatics and RNA stability assays. RESULTS: A total of 126 miRNAs were identified as m(6)A‐related miRNAs by Pearson's correlation analysis. Among them, the high level of miR‐30c‐5p was associated with good prognosis in OvCa patients. In vitro, the miR‐30c‐5p agomir lowered the m(6)A level and inhibited OvCa cell proliferation, migration, and invasion. The hub target genes of miR‐30c‐5p were identified as (i) XPO1, (ii) AGO1, (iii) HNRNPA2B1, of which m(6)A reader HNRNPA2B1 was highly expressed in OvCa tissues and related with poor prognosis. In vitro, knockdown of HNRNPA2B1 significantly reduced m(6)A level and hampered the proliferation and migration of OvCa cells. The inhibition of m(6)A reader HNRNPA2B1 attenuated the suppression of proliferation and migration and the low m(6)A level induced by the miR‐30c‐5p downregulation. Mechanistically, m(6)A reader HNRNPA2B1 might regulate CDK19 mRNA stability to alter m(6)A level. CONCLUSIONS: miR‐30c‐5p inhibits OvCa progression and reduces the m(6)A level by inhibiting m(6)A reader HNRNPA2B1, thus providing new insights into the m(6)A regulatory mechanism in OvCa. John Wiley and Sons Inc. 2022-10-18 /pmc/articles/PMC9972042/ /pubmed/36259156 http://dx.doi.org/10.1002/cam4.5246 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Wu, Qiulei
Li, Guoqing
Gong, Lanqing
Cai, Jing
Chen, Le
Xu, Xiaohan
Liu, Xiaoli
Zhao, Jing
Zeng, Ya
Gao, Rui
Yu, Lili
Wang, Zehua
Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer
title Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer
title_full Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer
title_fullStr Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer
title_full_unstemmed Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer
title_short Identification of miR‐30c‐5p as a tumor suppressor by targeting the m(6)A reader HNRNPA2B1 in ovarian cancer
title_sort identification of mir‐30c‐5p as a tumor suppressor by targeting the m(6)a reader hnrnpa2b1 in ovarian cancer
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972042/
https://www.ncbi.nlm.nih.gov/pubmed/36259156
http://dx.doi.org/10.1002/cam4.5246
work_keys_str_mv AT wuqiulei identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT liguoqing identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT gonglanqing identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT caijing identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT chenle identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT xuxiaohan identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT liuxiaoli identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT zhaojing identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT zengya identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT gaorui identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT yulili identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer
AT wangzehua identificationofmir30c5pasatumorsuppressorbytargetingthem6areaderhnrnpa2b1inovariancancer